Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 48736 records

$50,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Agreement Number:

156056

Duration: from May 1, 2020 to Oct 31, 2020
Description:

The specific objectives of this funding opportunity are:
•To address evidence gaps and build the evidence base for the mental health and substance use response to COVID-19.
•To provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the COVID-19 context (e.g. effective virtual service delivery models, or other models of care).

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Sudbury, Ontario, CA P3E 2C6

$3,550,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: WHO Solidarity Trial Scale-Up COVID-19 Funding Opportunity

Agreement Number:

155810

Duration: from May 1, 2020 to Apr 30, 2021
Description:

The specific objectives of this funding opportunity are:

-Accelerate the availability of high-quality and real-time evidence to support Canada’s rapid response to the global pandemic in order to better prevent, detect, treat and manage COVID-19;
-Test, and study the implementation of interventions to treat and manage COVID-19 by amplifying the WHO Solidarity trial in Canada;
-Enable Canadian engagement and coordination in international large-scale trials and better enable harmonized data collection, sharing of data, rapid large-scale evaluation of impact;
-Provide evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally; and
-Enhance local, national and/or international collaborative efforts, including in low- and middle-income countries, to mitigate the rapid spread of COVID-19 and related negative consequences.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Vancouver, British Columbia, CA V6T 1Z1

$50,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Agreement Number:

156046

Duration: from May 1, 2020 to Oct 31, 2020
Description:

The specific objectives of this funding opportunity are:
•To address evidence gaps and build the evidence base for the mental health and substance use response to COVID-19.
•To provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the COVID-19 context (e.g. effective virtual service delivery models, or other models of care).

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Hamilton, Ontario, CA L8N 3Z5

$50,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO

Agreement Number:

155802

Duration: from May 1, 2020 to Apr 30, 2021
Description:

This supplement builds on the objectives of the first Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity with a specific focus on:

Uncovering novel molecular and cellular mechanisms that contribute to the sex differences observed in COVID-19 severity.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: London, Ontario, CA N6A 3K7

$50,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Agreement Number:

156024

Duration: from May 1, 2020 to Oct 31, 2020
Description:

The specific objectives of this funding opportunity are:
•To address evidence gaps and build the evidence base for the mental health and substance use response to COVID-19.
•To provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the COVID-19 context (e.g. effective virtual service delivery models, or other models of care).

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Verdun, Quebec, CA H4H 1R3

$47,791.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Agreement Number:

156044

Duration: from May 1, 2020 to Oct 31, 2020
Description:

The specific objectives of this funding opportunity are:
•To address evidence gaps and build the evidence base for the mental health and substance use response to COVID-19.
•To provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the COVID-19 context (e.g. effective virtual service delivery models, or other models of care).

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5S 2S1

$50,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO

Agreement Number:

155798

Duration: from May 1, 2020 to Apr 30, 2021
Description:

This supplement builds on the objectives of the first Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity with a specific focus on:

Uncovering novel molecular and cellular mechanisms that contribute to the sex differences observed in COVID-19 severity.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, Ontario, CA M5G 2C4

$43,774.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Agreement Number:

156022

Duration: from May 1, 2020 to Oct 31, 2020
Description:

The specific objectives of this funding opportunity are:
•To address evidence gaps and build the evidence base for the mental health and substance use response to COVID-19.
•To provide current evidence on mental health services needs, delivery and related guidelines, practice and issues, placed in the COVID-19 context (e.g. effective virtual service delivery models, or other models of care).

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Calgary, Alberta, CA T2N 1N4

$40,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO

Agreement Number:

155797

Duration: from May 1, 2020 to Apr 30, 2021
Description:

This supplement builds on the objectives of the first Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity with a specific focus on:

Uncovering novel molecular and cellular mechanisms that contribute to the sex differences observed in COVID-19 severity.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Ottawa, Ontario, CA K1N 6N5

$1,000,000.00

May 1, 2020

Individual or sole proprietorship

Agreement:

Operating Grant: CRISM Urgent Guideline Activities Related to COVID-19

Agreement Number:

155916

Duration: from May 1, 2020 to Apr 30, 2021
Description:

The specific objectives of this funding opportunity are to:

Enable the development and dissemination of national guidelines related to prescribing, dispensing, and delivery of opioids and other narcotics during the COVID-19 pandemic to support people who use drugs (PWUD)
Identify opportunities to facilitate or improve individuals who use substances' access to medication during the pandemic, including OAT
Describe challenges faced by PWUD in relation to the pandemic, by directly engaging with PWUD and hearing their voices
Identify changes in drug use patterns and impacts during the pandemic
Assess the impacts of health interventions to support PWUD in relation to the pandemic and recommend which services should be retained post pandemic and/or integrated into future emergency response plans
Provide evidence to inform clinical and health system management and public health responses related to substance use, and/or decision-making and planning within and across jurisdictions in Canada

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Montréal, Quebec, CA H2X 0A9